BridgeMD
New treatment option for Stroke
Official title Effects of Different Modes of Action Observation Therapy on Swallowing Function After Stroke: a Study Based on fNIRS
ClinicalTrials.gov ID: NCT07184892
What this study is testing
- What it's testing
- Dysphagia is one of the most common symptoms of stroke patients, which seriously affects the quality of life of patients and delays the progress of rehabilitation. At present, the commonly used clinical swallowing treatment methods can achieve certain therapeutic effects, but the treatment effect of some patients is still not ideal.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 80
You may be able to join if
- 1: 1.n accordance with the diagnostic criteria formulated by the Fourth National Academic Conference on Cerebrovascular disease;
- 2: 2.Dysphagia was detected by water swallowing test;
- 3: 3.First onset, course of disease within 6 months, the condition is stable;
- 4: 4.Mini-mental state examination (MMSE) score, literacy \>=17 points, primary education \>=20 points, secondary education \>=24 points, can...
- 5: 5.Have a certain degree of sitting balance ability, can maintain a sitting position for 30 minutes;
You likely can't join if
- 1: Patients with impaired swallowing function due to other reasons;
- 2: Presence of tumors or other lesions in the mouth or throat;
- 3: Visual and hearing dysfunction;
- 4: The presence of agnosia, apraxia or unilateral neglect;
- 5: Severe cognitive impairment and mental and emotional instability can not cooperate with treatment;
- 6: Implantation or retention of ferromagnetic metals in the brain.
See the full eligibility criteria
- 1: 1.n accordance with the diagnostic criteria formulated by the Fourth National Academic Conference on Cerebrovascular disease;
- 2: 2.Dysphagia was detected by water swallowing test;
- 3: 3.First onset, course of disease within 6 months, the condition is stable;
- 4: 4.Mini-mental state examination (MMSE) score, literacy \>=17 points, primary education \>=20 points, secondary education \>=24 points, can understand and cooperate with treatment;
- 5: 5.Have a certain degree of sitting balance ability, can maintain a sitting position for 30 minutes;
- 6: 6.Aged 18-80 years old;
- 7: 7.The patient was informed and consented to this study, and the patient's family was informed and trained, and could cooperate with the adjuvant treatment of swallowing movement observation therapy in daily life.
- 1: Patients with impaired swallowing function due to other reasons;
- 2: Presence of tumors or other lesions in the mouth or throat;
- 3: Visual and hearing dysfunction;
- 4: The presence of agnosia, apraxia or unilateral neglect;
- 5: Severe cognitive impairment and mental and emotional instability can not cooperate with treatment;
- 6: Implantation or retention of ferromagnetic metals in the brain.
The study team makes the final eligibility decision.
Where it's taking place
- Jinan, Shandong, China
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 80 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Jinan, Shandong, China. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.